GlassScriptPhysician profile
James W Ratcliff
NPI 1326002064
$1,187.75
in general payments reported to CMS, 2019-2025
15 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.34 · 2020: $263 · 2021: $122 · 2022: $40.20 · 2023: $19.71 · 2024: $577 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $509.56 | 2020-2024 | Augment Injectable |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $136.43 | 2021-2023 | Jublia |
| Cook Medical LLC | $127.11 | 2024 | Cook |
| Wright Medical Technology, INC. | $100.29 | 2020 | |
| Treace Medical Concepts, INC. | $84.54 | 2025 | |
| Evolution Surgical, INC | $41.75 | 2024-2025 | |
| Arthrosurface Incorporated | $28.69 | 2019 | |
| Paragon 28, INC. | $27.08 | 2024 | Mini Monster |
| Horizon Therapeutics Plc | $23.88 | 2021 | |
| Calyxo, INC. | $22.95 | 2024 | Cvac Aspiration System |
| Tactile Systems Technology INC | $21.69 | 2022 | |
| Dynasplint Systems INC. | $20.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.09 | 2024 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $13.65 | 2019 | |
| Smith+Nephew, INC. | $13.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ratcliff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.